| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.2 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.2 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |